{"id":65659,"date":"2022-12-23T10:17:36","date_gmt":"2022-12-23T09:17:36","guid":{"rendered":"https:\/\/harlander-partner.eu\/konkurences-tiesibas\/veselibas-apgalvojumi\/"},"modified":"2026-06-05T23:15:10","modified_gmt":"2026-06-05T21:15:10","slug":"veselibas-apgalvojumi","status":"publish","type":"page","link":"https:\/\/harlander-partner.eu\/lv\/konkurences-tiesibas\/veselibas-apgalvojumi\/","title":{"rendered":"Vesel\u012bbas apgalvojumi"},"content":{"rendered":"\n<div class=\"wp-block-yoast-seo-table-of-contents yoast-table-of-contents\"><h2>Vesel\u012bbas apgalvojumi<\/h2><ul><li><a href=\"#h-health-claims\" data-level=\"2\">Vesel\u012bbas apgalvojumi<\/a><\/li><li><a href=\"#h-eu-weite-bestimmungen\" data-level=\"2\">ES m\u0113roga noteikumi<\/a><ul><li><a href=\"#h-anwendungsbereich\" data-level=\"3\">Piem\u0113ro\u0161anas joma<\/a><\/li><li><a href=\"#h-nahrwertbezogene-angaben\" data-level=\"3\">Uzturv\u0113rt\u012bbas nor\u0101des<\/a><\/li><li><a href=\"#h-gesundheitsbezogene-angaben\" data-level=\"3\">Vesel\u012bguma nor\u0101des<\/a><\/li><li><a href=\"#h-angaben-uber-die-reduktion-eines-krankheitsrisikos\" data-level=\"3\">Nor\u0101des par slim\u012bbu riska samazin\u0101\u0161anu<\/a><\/li><\/ul><\/li><li><a href=\"#h-wesentliche-inhalte-der-verordnung\" data-level=\"2\">Regulas galvenie saturs<\/a><ul><li><a href=\"#h-allgemeine-grundsatze-art-3-hcvo\" data-level=\"3\">Visp\u0101r\u012bgie principi (HCVO 3. pants)<\/a><\/li><li><a href=\"#h-allgemeine-bedingungen-art-5-hcvo\" data-level=\"3\">Visp\u0101r\u012bgie nosac\u012bjumi (HCVO 5. pants)<\/a><\/li><li><a href=\"#h-nahrwertkennzeichnungen-art-7-hcvo\" data-level=\"3\">Uzturv\u0113rt\u012bbas mar\u0137\u0113jums (HCVO 7. pants)<\/a><\/li><li><a href=\"#h-besondere-bedingungen-fur-nahrwertbezogene-angaben-art-8-und-9-hcvo\" data-level=\"3\">\u012apa\u0161ie nosac\u012bjumi uzturv\u0113rt\u012bbas nor\u0101d\u0113m (HCVO 8. un 9. pants)<\/a><\/li><li><a href=\"#h-besondere-bedingungen-fur-gesundheitsbezogene-angaben-art-10-ff-hcvo\" data-level=\"3\">\u012apa\u0161ie nosac\u012bjumi vesel\u012bguma nor\u0101d\u0113m (HCVO 10. pants un turpm\u0101kie)<\/a><\/li><\/ul><\/li><li><a href=\"#h-zulassungsverfahren\" data-level=\"2\">Apstiprin\u0101\u0161anas proced\u016bra<\/a><\/li><li><a href=\"#h-eu-gemeinschaftsregister-art-20-hcvo\" data-level=\"2\">ES Kopienas re\u0123istrs (HCVO 20. pants)<\/a><\/li><li><a href=\"#h-allgemeines-zur-verwendung-formulierung-von-angaben-im-sinne-der-hcvo\" data-level=\"2\">Visp\u0101r\u012bga inform\u0101cija par apgalvojumu izmanto\u0161anu\/formul\u0113\u0161anu HCVO izpratn\u0113<\/a><\/li><li><a href=\"#h-rechtsberatung-rechtsvertretung\" data-level=\"2\">Juridisk\u0101s konsult\u0101cijas \/ Juridisk\u0101 p\u0101rst\u0101v\u012bba<\/a><\/li><\/ul><\/div>\n<a class=\"mr-cta-link mr-cta-button-cal\" href=\"#h2-booking\" title=\"Bezmaksas s\u0101kotn\u0113j\u0101 konsult\u0101cija\"><span class=\"mr-cta-link-normal\">Izv\u0113lieties v\u0113lamo tik\u0161an\u0101s laiku tagad:<\/span><span class=\"mr-cta-link-bold\">Bezmaksas s\u0101kotn\u0113j\u0101 konsult\u0101cija<\/span><\/a>\n\n<h2 class=\"wp-block-heading\" id=\"h-health-claims\">Vesel\u012bbas apgalvojumi<\/h2>\n\n<p class=\"wp-block-paragraph\">Visp\u0101r\u012bgi run\u0101jot, ar vesel\u012bbas nor\u0101d\u0113m saprot vesel\u012bbu saist\u012btus apgalvojumus vai att\u0113lojumus par p\u0101rtikas produktiem, kas apraksta saist\u012bbu starp p\u0101rtikas produktu vai k\u0101du no t\u0101 sast\u0101vda\u013c\u0101m un vesel\u012bbu. Realit\u0101t\u0113 vesel\u012bbas nor\u0101des t\u0101d\u0113j\u0101di liecina, ka p\u0101rtikas produktam vai t\u0101 sast\u0101vda\u013cai ir \u012bpa\u0161a ietekme uz vesel\u012bbu (piem\u0113ram: kalcijs ir labs kauliem u.c.).<\/p>\n<a class=\"mr-cta-link mr-cta-button-cal\" href=\"#h2-booking\" title=\"Bezmaksas s\u0101kotn\u0113j\u0101 konsult\u0101cija\"><span class=\"mr-cta-link-normal\">Izv\u0113lieties v\u0113lamo tik\u0161an\u0101s laiku tagad:<\/span><span class=\"mr-cta-link-bold\">Bezmaksas s\u0101kotn\u0113j\u0101 konsult\u0101cija<\/span><\/a>\n\n<h2 class=\"wp-block-heading\" id=\"h-eu-weite-bestimmungen\">ES m\u0113roga noteikumi<\/h2>\n\n<p class=\"wp-block-paragraph\">T\u0101 k\u0101 sabiedr\u012bb\u0101 arvien vair\u0101k p\u0101rtikas produkti tika mar\u0137\u0113ti ar uzturv\u0113rt\u012bbas un vesel\u012bbas nor\u0101d\u0113m un ar \u0161\u012bm nor\u0101d\u0113m tika reklam\u0113ti, bija nepiecie\u0161ams nodro\u0161in\u0101t pat\u0113r\u0113t\u0101jiem augstu aizsardz\u012bbas l\u012bmeni un atvieglot vi\u0146iem izv\u0113li, nodro\u0161inot, ka tirdzniec\u012bb\u0101 eso\u0161ie produkti ir dro\u0161i un tiem ir atbilsto\u0161s mar\u0137\u0113jums. Eiropas l\u012bmen\u012b t\u0101d\u0113\u013c ir sp\u0113k\u0101 ES Vesel\u012bbas nor\u0101\u017eu regula 1924\/2007. Ievie\u0161ot \u0161o regulu, bija paredz\u0113ts pan\u0101kt visaptvero\u0161u saska\u0146o\u0161anu p\u0101rtikas ties\u012bbu jom\u0101 un vienlaikus nodro\u0161in\u0101t augstu pat\u0113r\u0113t\u0101ju aizsardz\u012bbas l\u012bmeni.<\/p>\n\n<p class=\"wp-block-paragraph\">Regula attiecas gan uz p\u0101rtikas produktiem, gan uztura bag\u0101tin\u0101t\u0101jiem, tikl\u012bdz tie tiek laisti tirg\u016b k\u0101 p\u0101rtikas produkti un tiek reklam\u0113ti k\u0101 t\u0101di. Uztura bag\u0101tin\u0101t\u0101ji ir kvalific\u0113jami k\u0101 \u201ep\u0101rtikas produkti\u201d Direkt\u012bvas 2002\/46\/EK 2. panta izpratn\u0113, ja tie ir paredz\u0113ti uztura papildin\u0101\u0161anai, sast\u0101v no viena vai vair\u0101ku uzturvielu koncentr\u0101tiem ar uzturv\u0113rt\u012bbu specifisku iedarb\u012bbu un tiek laisti tirg\u016b doz\u0113t\u0101 veid\u0101, piem\u0113ram, kapsulu vai citu z\u0101\u013cu formu veid\u0101. \u0160\u012b regula neattiecas uz kosm\u0113tikas l\u012bdzek\u013ciem vai z\u0101l\u0113m, jo tos nevar uzskat\u012bt par p\u0101rtikas produktiem.<\/p>\n\n<h3 class=\"wp-block-heading\" id=\"h-anwendungsbereich\">Piem\u0113ro\u0161anas joma<\/h3>\n\n<p class=\"wp-block-paragraph\">Vesel\u012bbas apgalvojumu regula attiecas uz vis\u0101m uzturv\u0113rt\u012bbas un vesel\u012bguma nor\u0101d\u0113m, kas tiek izmantotas komerci\u0101l\u0101 noform\u0113jum\u0101, mar\u0137\u0113jum\u0101 (iepakojum\u0101 un lieto\u0161anas instrukcij\u0101), k\u0101 ar\u012b jebk\u0101da veida rekl\u0101m\u0101 attiec\u012bb\u0101 uz p\u0101rtikas produktiem, kas tiek pieg\u0101d\u0101ti galapat\u0113r\u0113t\u0101jiem.<\/p>\n\n<p class=\"wp-block-paragraph\">T\u0101 attiecas ar\u012b uz p\u0101rtikas produktiem, kas paredz\u0113ti restor\u0101niem, slimn\u012bc\u0101m, skol\u0101m, \u0113dn\u012bc\u0101m un l\u012bdz\u012bg\u0101m sabiedrisk\u0101s \u0113din\u0101\u0161anas iest\u0101d\u0113m.<\/p>\n\n<p class=\"wp-block-paragraph\">Pre\u010du z\u012bmes, citi z\u012bmolu nosaukumi un fant\u0101zijas apz\u012bm\u0113jumi, kurus var interpret\u0113t k\u0101 uzturv\u0113rt\u012bbas vai vesel\u012bbas nor\u0101des un kas t\u0101d\u0113j\u0101di rada iespaidu, ka past\u0101v pozit\u012bva \u012bpa\u0161\u012bba starp nosaukumu un vesel\u012bbu, ar\u012b ietilpst regulas darb\u012bbas jom\u0101. T\u0101d\u0113j\u0101di ar\u012b z\u012bmolos vai nosaukumos ietvertajiem v\u0113st\u012bjumiem ir j\u0101atbilst regulas pie\u013caujam\u012bbas krit\u0113rijiem, t.i., tie jo \u012bpa\u0161i ir pak\u013cauti maldin\u0101\u0161anas aizliegumam un citiem visp\u0101r\u0113jiem pie\u013caujam\u012bbas nosac\u012bjumiem, kas noteikti 5.-7. pant\u0101. Ja z\u012bmola vai apz\u012bm\u0113juma saturs atbilst noteikumiem, t.i., tas nav maldino\u0161s vai nav pretrun\u0101 ar visp\u0101r\u0113jiem lieto\u0161anas nosac\u012bjumiem attiec\u012bb\u0101 uz p\u0101rtikas produktiem, uz kuriem tas attiecas, z\u012bmolu vai apz\u012bm\u0113jumu var izmantot bez ofici\u0101las apstiprin\u0101\u0161anas proced\u016bras saska\u0146\u0101 ar HCVO 15.-18. pantu, ja vienlaikus papildus tiek izmantota konkr\u0113ta uzturv\u0113rt\u012bbas vai vesel\u012bbas nor\u0101de no sarakstiem.<\/p>\n\n<p class=\"wp-block-paragraph\">Regula tiek piem\u0113rota ierobe\u017eoti<\/p>\n\n<ul class=\"wp-block-list\">\n<li>fas\u0113tiem p\u0101rtikas produktiem (ieskaitot svaigus produktus, piem\u0113ram, aug\u013cus, d\u0101rze\u0146us vai maizi), kas tiek pied\u0101v\u0101ti p\u0101rdo\u0161anai galapat\u0113r\u0113t\u0101jam vai sabiedrisk\u0101s \u0113din\u0101\u0161anas iest\u0101d\u0113m, un p\u0101rtikas produktiem, kas tiek iepakoti p\u0113c pirc\u0113ja v\u0113l\u0113\u0161an\u0101s p\u0101rdo\u0161anas viet\u0101 vai ir iepriek\u0161 iepakoti t\u016bl\u012bt\u0113jai p\u0101rdo\u0161anai (\u0161aj\u0101 gad\u012bjum\u0101 regulas 7. pants un 10. panta 2. punkta a) un b) apak\u0161punkts neattiecas \u2013 t\u0101d\u0113j\u0101di uzturv\u0113rt\u012bbas mar\u0137\u0113jums neb\u016btu oblig\u0101ts).<\/li>\n\n\n\n<li>pre\u010du z\u012bm\u0113m, z\u012bmolu nosaukumiem vai fant\u0101zijas apz\u012bm\u0113jumiem, kas tiek izmantoti p\u0101rtikas produkta mar\u0137\u0113jum\u0101, noform\u0113jum\u0101 vai rekl\u0101m\u0101 un var tikt uztverti k\u0101 uzturv\u0113rt\u012bbas vai vesel\u012bguma nor\u0101de (1. panta 3. punkts) <\/li>\n<\/ul>\n\n<h3 class=\"wp-block-heading\" id=\"h-nahrwertbezogene-angaben\">Uzturv\u0113rt\u012bbas nor\u0101des<\/h3>\n\n<p class=\"wp-block-paragraph\">Ar t\u0101m saprot nor\u0101des, ar kur\u0101m tiek pazi\u0146ots, ieteikts vai pat netie\u0161i nor\u0101d\u012bts, ka p\u0101rtikas produktam ir \u012bpa\u0161as pozit\u012bvas uzturv\u0113rt\u012bbas \u012bpa\u0161\u012bbas, pamatojoties uz ener\u0123iju (kaloriju v\u0113rt\u012bbu), ko tas sniedz\/sniedz samazin\u0101t\u0101 vai palielin\u0101t\u0101 daudzum\u0101\/nesniedz, un\/vai uzturviel\u0101m vai cit\u0101m viel\u0101m, ko tas satur\/satur samazin\u0101t\u0101 vai palielin\u0101t\u0101 daudzum\u0101\/nesatur.<\/p>\n\n<p class=\"wp-block-paragraph\">Piem\u0113rs:<\/p>\n\n<ul class=\"wp-block-list\">\n<li>Samazin\u0101ts ener\u0123ijas daudzums<\/li>\n\n\n\n<li>Zems tauku saturs<\/li>\n\n\n\n<li>Bez cukura piedevas<\/li>\n\n\n\n<li>Viegls<\/li>\n\n\n\n<li>Augsts kalcija saturs<\/li>\n\n\n\n<li>Bag\u0101ts ar kalciju<\/li>\n<\/ul>\n\n<h3 class=\"wp-block-heading\" id=\"h-gesundheitsbezogene-angaben\">Vesel\u012bguma nor\u0101des<\/h3>\n\n<p class=\"wp-block-paragraph\">Ar t\u0101m saprot jebkuru nor\u0101di, ar kuru tiek pazi\u0146ots, ieteikts vai pat netie\u0161i nor\u0101d\u012bts, ka past\u0101v saist\u012bba starp p\u0101rtikas produktu kategoriju, p\u0101rtikas produktu vai k\u0101du no t\u0101 sast\u0101vda\u013c\u0101m un vesel\u012bbu.<\/p>\n\n<p class=\"wp-block-paragraph\">Piem\u0113rs:<\/p>\n\n<ul class=\"wp-block-list\">\n<li>Satur vesel\u012bgo C vitam\u012bnu<\/li>\n\n\n\n<li>Ar C vitam\u012bnu, lai saglab\u0101tu formu<\/li>\n\n\n\n<li>Piens ir vesel\u012bgs<\/li>\n\n\n\n<li>E vitam\u012bns paaugstina koncentr\u0113\u0161an\u0101s sp\u0113jas<\/li>\n\n\n\n<li>E vitam\u012bns ir antioksidants, kas aizsarg\u0101 \u0137erme\u0146a \u0161\u016bnas no br\u012bvajiem radik\u0101\u013ciem<\/li>\n\n\n\n<li>Kalcijs ir nepiecie\u0161ams norm\u0101lu kaulu un zobu uztur\u0113\u0161anai<\/li>\n<\/ul>\n\n<h3 class=\"wp-block-heading\" id=\"h-angaben-uber-die-reduktion-eines-krankheitsrisikos\">Nor\u0101des par slim\u012bbu riska samazin\u0101\u0161anu<\/h3>\n\n<p class=\"wp-block-paragraph\">Ar t\u0101m saprot jebkuru nor\u0101di, ar kuru tiek pazi\u0146ots, ieteikts vai pat netie\u0161i nor\u0101d\u012bts, ka p\u0101rtikas produktu kategorijas, p\u0101rtikas produkta vai k\u0101das p\u0101rtikas produkta sast\u0101vda\u013cas pat\u0113ri\u0146\u0161 iev\u0113rojami samazina k\u0101da riska faktoru cilv\u0113ka slim\u012bbas att\u012bst\u012bbai.<\/p>\n\n<p class=\"wp-block-paragraph\">Piem\u0113rs:<\/p>\n\n<ul class=\"wp-block-list\">\n<li>Auzu beta-glik\u0101ns pier\u0101d\u0101mi samazina holester\u012bna l\u012bmeni asin\u012bs<\/li>\n\n\n\n<li>Augsts holester\u012bna l\u012bmenis ir viens no riska faktoriem koron\u0101r\u0101s sirds slim\u012bbas att\u012bst\u012bbai<\/li>\n<\/ul>\n<a class=\"mr-cta-link mr-cta-button-cal\" href=\"#h2-booking\" title=\"Bezmaksas s\u0101kotn\u0113j\u0101 konsult\u0101cija\"><span class=\"mr-cta-link-normal\">Izv\u0113lieties v\u0113lamo tik\u0161an\u0101s laiku tagad:<\/span><span class=\"mr-cta-link-bold\">Bezmaksas s\u0101kotn\u0113j\u0101 konsult\u0101cija<\/span><\/a>\n\n<h2 class=\"wp-block-heading\" id=\"h-wesentliche-inhalte-der-verordnung\">Regulas galvenie saturs<\/h2>\n\n<p class=\"wp-block-paragraph\">B\u016bt\u012bb\u0101 regula papildus visp\u0101r\u0113jiem principiem nosaka, ar k\u0101diem nosac\u012bjumiem var sniegt uzturv\u0113rt\u012bbas un vesel\u012bbas nor\u0101des par p\u0101rtikas produktiem. Saturs vai priek\u0161noteikumi attiec\u012bb\u0101 uz katru nor\u0101di da\u013c\u0113ji ir \u013coti sare\u017e\u0123\u012bti un neskaidri:<\/p>\n\n<h3 class=\"wp-block-heading\" id=\"h-allgemeine-grundsatze-art-3-hcvo\">Visp\u0101r\u012bgie principi (HCVO 3. pants)<\/h3>\n\n<p class=\"wp-block-paragraph\">Vispirms regula nosaka visp\u0101r\u0113jus principus, kas j\u0101iev\u0113ro attiec\u012bb\u0101 uz vis\u0101m nor\u0101d\u0113m. Attiec\u012bgi nor\u0101des (uzturv\u0113rt\u012bbas un\/vai vesel\u012bbas nor\u0101des) nedr\u012bkst<\/p>\n\n<ul class=\"wp-block-list\">\n<li>nepatiesas, neskaidras vai maldino\u0161as;<\/li>\n\n\n\n<li>rad\u012bt \u0161aubas par citu p\u0101rtikas produktu dro\u0161\u012bbu un\/vai uzturv\u0113rt\u012bbu. (\u0160eit aizliegums ir v\u0113rsts uz citu, sal\u012bdzin\u0101mu produktu noniecin\u0101\u0161anu);<\/li>\n\n\n\n<li>mudin\u0101t uz p\u0101rm\u0113r\u012bgu p\u0101rtikas produkta pat\u0113ri\u0146u vai to att\u0113lot labv\u0113l\u012bgi;<\/li>\n\n\n\n<li>nor\u0101d\u012bt vai cit\u0101di likt saprast, ka sabalans\u0113ts un daudzveid\u012bgs uzturs kopum\u0101 nevar nodro\u0161in\u0101t atbilsto\u0161u uzturvielu daudzumu;<\/li>\n<\/ul>\n\n<p class=\"wp-block-paragraph\">ietekm\u0113t pat\u0113r\u0113t\u0101ja pirkuma l\u0113mumu ar satrauco\u0161\u0101m nor\u0101d\u0113m, kas nor\u0101da uz visp\u0101r\u0113j\u0101m \u0137erme\u0146a funkciju izmai\u0146\u0101m, t\u0101d\u0113j\u0101di liekot dom\u0101t, ka vi\u0146\u0161 pats var\u0113tu g\u016bt labumu no t\u0101.<\/p>\n<a class=\"mr-cta-link mr-cta-button-cal\" href=\"#h2-booking\" title=\"Bezmaksas s\u0101kotn\u0113j\u0101 konsult\u0101cija\"><span class=\"mr-cta-link-normal\">Izv\u0113lieties v\u0113lamo tik\u0161an\u0101s laiku tagad:<\/span><span class=\"mr-cta-link-bold\">Bezmaksas s\u0101kotn\u0113j\u0101 konsult\u0101cija<\/span><\/a>\n\n<h3 class=\"wp-block-heading\" id=\"h-allgemeine-bedingungen-art-5-hcvo\">Visp\u0101r\u012bgie nosac\u012bjumi (HCVO 5. pants)<\/h3>\n\n<p class=\"wp-block-paragraph\">Papildus visp\u0101r\u0113jiem principiem regula nosaka visp\u0101r\u0113jus nosac\u012bjumus uzturv\u0113rt\u012bbas un vesel\u012bbas nor\u0101d\u0113m. Attiec\u012bgi uzturv\u0113rt\u012bbas un vesel\u012bbas nor\u0101des dr\u012bkst izmantot tikai tad, ja<\/p>\n\n<ul class=\"wp-block-list\">\n<li>nor\u0101d\u012bt\u0101 iedarb\u012bba ir visp\u0101ratz\u012bta un zin\u0101tniski pier\u0101d\u012bta;<\/li>\n\n\n\n<li>min\u0113t\u0101 viela produkt\u0101 ir pietiekam\u0101 daudzum\u0101 (vai nav), lai pan\u0101ktu apgalvoto iedarb\u012bbu;<\/li>\n\n\n\n<li>\u2013 cikt\u0101l tas ir piem\u0113rojams \u2013 min\u0113t\u0101 viela ir t\u0101d\u0101 form\u0101, kas ir pieejama organismam (p\u0113c uztura ekspertu dom\u0101m, \u0161is termins tiek defin\u0113ts k\u0101 attiec\u012bg\u0101s uzturvielas procentu\u0101la uzs\u016bk\u0161an\u0101s organism\u0101, \u0146emot v\u0113r\u0101 uzs\u016bk\u0161an\u0101s daudzumu un \u0101trumu). Biopieejam\u012bbas krit\u0113rijs ir atkar\u012bgs no da\u017e\u0101diem uztura faktoriem un t\u0101d\u0113\u013c da\u017eos gad\u012bjumos ir tikai fakultat\u012bvs, t.i., \u201ecikt\u0101l tas ir piem\u0113rojams\u201d, jo nor\u0101des, kas nor\u0101da uz samazin\u0101tu uzturvielu saturu, k\u0101 tas ir, piem\u0113ram, 5. panta 1. punkta b) apak\u0161punkta ii) punkt\u0101, dabiski nevar izpild\u012bt \u0161o priek\u0161noteikumu.<\/li>\n\n\n\n<li>parastais produkta pat\u0113ri\u0146a daudzums ir piem\u0113rots, lai pan\u0101ktu nor\u0101d\u012bto iedarb\u012bbu;<\/li>\n\n\n\n<li>ir izpild\u012bti \u012bpa\u0161ie nosac\u012bjumi (skat\u012bt t\u0101l\u0101k);<\/li>\n\n\n\n<li>nor\u0101de attiecas uz pat\u0113ri\u0146am gatavu p\u0101rtikas produktu.<\/li>\n<\/ul>\n\n<p class=\"wp-block-paragraph\">Turkl\u0101t uzturv\u0113rt\u012bbas un vesel\u012bbas nor\u0101des dr\u012bkst izmantot tikai tad, ja var sagaid\u012bt, ka vidusm\u0113ra pat\u0113r\u0113t\u0101js saprat\u012bs nor\u0101d\u012bto pozit\u012bvo ietekmi. T\u0101d\u0113\u013c jau formul\u0113jum\u0101 ir j\u0101piev\u0113r\u0161 uzman\u012bba tam, lai tas jebkur\u0101 gad\u012bjum\u0101 b\u016btu pat\u0113r\u0113t\u0101jam draudz\u012bgs.<\/p>\n<a class=\"mr-cta-link mr-cta-button-cal\" href=\"#h2-booking\" title=\"Bezmaksas s\u0101kotn\u0113j\u0101 konsult\u0101cija\"><span class=\"mr-cta-link-normal\">Izv\u0113lieties v\u0113lamo tik\u0161an\u0101s laiku tagad:<\/span><span class=\"mr-cta-link-bold\">Bezmaksas s\u0101kotn\u0113j\u0101 konsult\u0101cija<\/span><\/a>\n\n<h3 class=\"wp-block-heading\" id=\"h-nahrwertkennzeichnungen-art-7-hcvo\">Uzturv\u0113rt\u012bbas mar\u0137\u0113jums (HCVO 7. pants)<\/h3>\n\n<p class=\"wp-block-paragraph\">Visp\u0101r\u0113ji iev\u0113rojamiem principiem un visp\u0101r\u0113jiem nosac\u012bjumiem galu gal\u0101 pievienojas ar\u012b mar\u0137\u0113\u0161anas noteikumi k\u0101 priek\u0161noteikums. Attiec\u012bgi p\u0101rtikas produktiem, kuriem ir gan uzturv\u0113rt\u012bbas, gan vesel\u012bbas nor\u0101des, oblig\u0101ti j\u0101ietver uzturv\u0113rt\u012bbas mar\u0137\u0113jums. <\/p>\n\n<p class=\"wp-block-paragraph\">Regula \u0161eit visp\u0101r\u012bgi atsaucas uz Regulu (ES) Nr. 1169\/2011 (<a href=\"https:\/\/eur-lex.europa.eu\/legal-content\/DE\/TXT\/HTML\/?uri=CELEX:02011R1169-20180101&amp;from=EN\">https:\/\/eur-lex.europa.eu\/legal-content\/DE\/TXT\/HTML\/?uri=CELEX:02011R1169-20180101&amp;from=EN<\/a>). Attiec\u012bgi saska\u0146\u0101 ar \u0161\u012bs regulas 30. panta 1. punktu ir j\u0101nor\u0101da ener\u0123\u0113tisk\u0101 v\u0113rt\u012bba, tauku, pies\u0101tin\u0101to tauksk\u0101bju, og\u013chidr\u0101tu, cukura, olbaltumvielu un s\u0101ls daudzums.<\/p>\n\n<p class=\"wp-block-paragraph\">Turkl\u0101t viel\u0101m, kas ir uzturv\u0113rt\u012bbas vai vesel\u012bbas nor\u0101des priek\u0161mets un kas nepar\u0101d\u0101s uzturv\u0113rt\u012bbas mar\u0137\u0113jum\u0101, attiec\u012bgais daudzums j\u0101nor\u0101da taj\u0101 pa\u0161\u0101 redzam\u012bbas lauk\u0101 tie\u0161\u0101 \u0161\u012b uzturv\u0113rt\u012bbas mar\u0137\u0113juma tuvum\u0101. Uztura bag\u0101tin\u0101t\u0101jiem mar\u0137\u0113jum\u0101 piem\u0113ro \u012bpa\u0161\u0101s pras\u012bbas, kas noteiktas Direkt\u012bvas 2002\/46\/EK 8. pant\u0101 (<a href=\"https:\/\/eur-lex.europa.eu\/legal-content\/DE\/TXT\/PDF\/?uri=CELEX:02002L0046-20220930&amp;from=EN\">https:\/\/eur-lex.europa.eu\/legal-content\/DE\/TXT\/PDF\/?uri=CELEX:02002L0046-20220930&amp;from=EN<\/a>). <\/p>\n<a class=\"mr-cta-link mr-cta-button-cal\" href=\"#h2-booking\" title=\"Bezmaksas s\u0101kotn\u0113j\u0101 konsult\u0101cija\"><span class=\"mr-cta-link-normal\">Izv\u0113lieties v\u0113lamo tik\u0161an\u0101s laiku tagad:<\/span><span class=\"mr-cta-link-bold\">Bezmaksas s\u0101kotn\u0113j\u0101 konsult\u0101cija<\/span><\/a>\n\n<h3 class=\"wp-block-heading\" id=\"h-besondere-bedingungen-fur-nahrwertbezogene-angaben-art-8-und-9-hcvo\">\u012apa\u0161ie nosac\u012bjumi uzturv\u0113rt\u012bbas nor\u0101d\u0113m (HCVO 8. un 9. pants)<\/h3>\n\n<p class=\"wp-block-paragraph\">Regulas 8. pants nosaka, ka uzturv\u0113rt\u012bbas nor\u0101des ir at\u013cautas tikai tad, ja t\u0101s ir noteiktas regulas pielikum\u0101 aprakst\u012bt\u0101 form\u0101 un turkl\u0101t kopum\u0101 atbilst regulas pras\u012bb\u0101m (skat\u012bt iepriek\u0161, visp\u0101r\u012bgie principi un nosac\u012bjumi, mar\u0137\u0113\u0161anas pras\u012bbas).<\/p>\n\n<p class=\"wp-block-paragraph\">Saraksts, kas atrodas pielikum\u0101, ir nosl\u0113gta vien\u012bba. T\u0101d\u0113j\u0101di nor\u0101des, kas taj\u0101 nav nor\u0101d\u012btas, vairs nedr\u012bkst izmantot. Min\u0113tais pielikums ietver saska\u0146o\u0161anas ideju, jo \u012bpa\u0161i t\u0101p\u0113c, ka atsevi\u0161\u0137\u0101m dal\u012bbvalst\u012bm pirms regulas st\u0101\u0161an\u0101s sp\u0113k\u0101 bija at\u0161\u0137ir\u012bgi noteikumi attiec\u012bb\u0101 uz uzturv\u0113rt\u012bbas nor\u0101d\u0113m.<\/p>\n\n<p class=\"wp-block-paragraph\">Pat ja \u0161\u012bs nor\u0101des tiek uzskat\u012btas par tie\u0161i piem\u0113rojam\u0101m un par augst\u0101ka ranga ties\u012bbu aktiem, t\u0101s ir tikai \u201enor\u0101des\u201d. T\u0101d\u0113j\u0101di uzturv\u0113rt\u012bbas nor\u0101dei p\u0113c b\u016bt\u012bbas j\u0101b\u016bt ietvertai pielikum\u0101, bet tai nav j\u0101atbilst prec\u012bzam tur nor\u0101d\u012bt\u0101 apgalvojuma formul\u0113jumam. \u0160im atvieglotajam pielietojumam ir j\u0101izmanto vidusm\u0113ra pat\u0113r\u0113t\u0101ja izpratne. T\u0101d\u0113j\u0101di ir at\u013cauts izmantot sinon\u012bmus, ja pat\u0113r\u0113t\u0101js var atpaz\u012bt saist\u012bbu ar nor\u0101di un pielikum\u0101 eso\u0161o formul\u0113jumu. Piem\u0113ram, v\u0101rda \u201e\u0161\u0137iedrvielu avots\u201d viet\u0101 var izmantot ar\u012b formul\u0113jumu \u201ebag\u0101ts ar \u0161\u0137iedrviel\u0101m\u201d.<\/p>\n\n<p class=\"wp-block-paragraph\">Iest\u0101de var papla\u0161in\u0101t vai piel\u0101got pielikum\u0101 eso\u0161o sarakstu p\u0113c regul\u0101 min\u0113t\u0101s proced\u016bras veik\u0161anas. T\u0101d\u0113j\u0101di tiek nodro\u0161in\u0101ts, ka nor\u0101des atbilst jaun\u0101kajiem tehnikas un zin\u0101tnes sasniegumiem.<\/p>\n\n<p class=\"wp-block-paragraph\">Sal\u012bdzin\u0101jums attiec\u012bb\u0101 uz uzturv\u0113rt\u012bbas nor\u0101d\u0113m ar citiem p\u0101rtikas produktiem ir at\u013cauts tikai tad, ja tas tiek veikts starp vienas kategorijas p\u0101rtikas produktiem un \u0146emot v\u0113r\u0101 vair\u0101kus \u0161\u012bs kategorijas p\u0101rtikas produktus (Regulas 9. pants).<\/p>\n<a class=\"mr-cta-link mr-cta-button-cal\" href=\"#h2-booking\" title=\"Bezmaksas s\u0101kotn\u0113j\u0101 konsult\u0101cija\"><span class=\"mr-cta-link-normal\">Izv\u0113lieties v\u0113lamo tik\u0161an\u0101s laiku tagad:<\/span><span class=\"mr-cta-link-bold\">Bezmaksas s\u0101kotn\u0113j\u0101 konsult\u0101cija<\/span><\/a>\n\n<h3 class=\"wp-block-heading\" id=\"h-besondere-bedingungen-fur-gesundheitsbezogene-angaben-art-10-ff-hcvo\">\u012apa\u0161ie nosac\u012bjumi vesel\u012bguma nor\u0101d\u0113m (HCVO 10. pants un turpm\u0101kie)<\/h3>\n\n<p class=\"wp-block-paragraph\">Vesel\u012bbas nor\u0101des ir aizliegtas, ja t\u0101s neatbilst visp\u0101r\u012bgaj\u0101m pras\u012bb\u0101m (skat\u012bt iepriek\u0161) un \u0161\u012bs regulas \u012bpa\u0161aj\u0101m pras\u012bb\u0101m (skat\u012bt zem\u0101k). Turkl\u0101t vesel\u012bbas nor\u0101d\u0113m j\u0101b\u016bt iek\u013caut\u0101m apstiprin\u0101to nor\u0101\u017eu sarakst\u0101 (saska\u0146\u0101 ar 13. un 14. pantu). <\/p>\n\n<p class=\"wp-block-paragraph\">\u0160\u0101das nor\u0101des dr\u012bkst izmantot tikai tad, ja mar\u0137\u0113jum\u0101 vai, ja \u0161\u0101da mar\u0137\u0113juma nav, p\u0101rtikas produktu noform\u0113jum\u0101 un p\u0101rtikas produktu rekl\u0101m\u0101 ir \u0161\u0101da papildu inform\u0101cija:<\/p>\n\n<ul class=\"wp-block-list\">\n<li>nor\u0101de par daudzveid\u012bga un sabalans\u0113ta uztura un vesel\u012bga dz\u012bvesveida noz\u012bmi<\/li>\n\n\n\n<li>inform\u0101cija par p\u0101rtikas produkta daudzumu un pat\u0113ri\u0146a veidu, kas nepiecie\u0161ams, lai pan\u0101ktu apgalvoto pozit\u012bvo iedarb\u012bbu.<\/li>\n<\/ul>\n\n<p class=\"wp-block-paragraph\">Piem\u0113ram, ir j\u0101nor\u0101da, vai tiek pie\u0146emts, ka nor\u0101d\u012bt\u0101 ietekme tiks pan\u0101kta, ja p\u0101rtikas produktu pat\u0113r\u0113s tikai vienu reizi dien\u0101 vai vair\u0101kas reizes dienas laik\u0101. Turkl\u0101t nor\u0101de nedr\u012bkst mudin\u0101t uz p\u0101rm\u0113r\u012bgu p\u0101rtikas produkta pat\u0113ri\u0146u vai to atbalst\u012bt. Gad\u012bjumos, kad to nevar pan\u0101kt, no vesel\u012bbas nor\u0101des j\u0101atsak\u0101s.<\/p>\n\n<ul class=\"wp-block-list\">\n<li>attiec\u012bg\u0101 gad\u012bjum\u0101 br\u012bdin\u0101jums person\u0101m, kur\u0101m b\u016btu j\u0101izvair\u0101s no \u0161\u012b p\u0101rtikas produkta lieto\u0161anas, un<\/li>\n\n\n\n<li>atbilsto\u0161s br\u012bdin\u0101jums par produktiem, kuri p\u0101rm\u0113r\u012bgas lieto\u0161anas gad\u012bjum\u0101 var\u0113tu rad\u012bt vesel\u012bbas apdraud\u0113jumu.<\/li>\n<\/ul>\n\n<p class=\"wp-block-paragraph\">Visai \u0161ai inform\u0101cijai j\u0101b\u016bt da\u013cai no mar\u0137\u0113juma. Ja \u0161\u0101da mar\u0137\u0113juma nav, tai j\u0101b\u016bt da\u013cai no p\u0101rtikas produkta noform\u0113juma un p\u0101rtikas produktu rekl\u0101mas. Ja, piem\u0113ram, visp\u0101r\u0113j\u0101 p\u0101rtikas produkta rekl\u0101m\u0101 tiek izmantota vesel\u012bbas nor\u0101de (piem\u0113ram, ga\u013ca, piena produkti utt.), kas neattiecas uz konkr\u0113tu produktu, tad \u0161\u012bs oblig\u0101t\u0101s nor\u0101des j\u0101par\u0101da \u0161\u012b p\u0101rtikas produkta rekl\u0101m\u0101 un noform\u0113jum\u0101.<\/p>\n<a class=\"mr-cta-link mr-cta-button-cal\" href=\"#h2-booking\" title=\"Bezmaksas s\u0101kotn\u0113j\u0101 konsult\u0101cija\"><span class=\"mr-cta-link-normal\">Izv\u0113lieties v\u0113lamo tik\u0161an\u0101s laiku tagad:<\/span><span class=\"mr-cta-link-bold\">Bezmaksas s\u0101kotn\u0113j\u0101 konsult\u0101cija<\/span><\/a>\n\n<p class=\"wp-block-paragraph\"><strong>Papildu inform\u0101cija:<\/strong><\/p>\n\n<p class=\"wp-block-paragraph\"><em>Noform\u0113jums: &#8220;Ar to saprot \u012bpa\u0161i formu, izskatu, iepakojumu, t\u0101 izk\u0101rtojuma veidu un vidi, kur\u0101 tas tiek pied\u0101v\u0101ts.<\/em><\/p>\n\n<p class=\"wp-block-paragraph\">Nespecifiskas (vesel\u012bbas) nor\u0101des, kas sola labv\u0113l\u012bgu ietekmi uz vesel\u012bbu un visp\u0101r\u0113jo labsaj\u016btu, ir at\u013cautas tikai tad, ja t\u0101m ir pievienota \u012bpa\u0161a nor\u0101de, kas iek\u013cauta sarakst\u0101 saska\u0146\u0101 ar 13. vai 14. pantu. \u0160\u012b noteikuma pamatojums ir t\u0101ds, ka \u0161\u0101d\u0101m nor\u0101d\u0113m ir vienreiz\u0113js raksturs ar visp\u0101r\u0113ju formul\u0113jumu. T\u0101d\u0113j\u0101di t\u0101 ir t\u0101 saukt\u0101 \u201ekombin\u0113t\u0101 risin\u0101juma\u201d. <\/p>\n\n<p class=\"wp-block-paragraph\">Nespecifisku vesel\u012bguma nor\u0101\u017eu piem\u0113ri ir:<\/p>\n\n<ul class=\"wp-block-list\">\n<li>Piens ir vesel\u012bgs<\/li>\n\n\n\n<li>Satur vesel\u012bgo C vitam\u012bnu<\/li>\n\n\n\n<li>Fitnesa maiz\u012btes<\/li>\n<\/ul>\n\n<p class=\"wp-block-paragraph\">Katr\u0101 zi\u0146\u0101 nav pie\u013caujamas vesel\u012bguma nor\u0101des (12. pants),<\/p>\n\n<ul class=\"wp-block-list\">\n<li>kas rada iespaidu, ka, atsakoties no p\u0101rtikas produkta, var\u0113tu tikt kait\u0113ts vesel\u012bbai;<\/li>\n\n\n\n<li>par svara zaud\u0113\u0161anas ilgumu un apjomu;<\/li>\n\n\n\n<li>kas atsaucas uz atsevi\u0161\u0137u \u0101rstu vai medic\u012bnas profesiju p\u0101rst\u0101vju un apvien\u012bbu, kas nav min\u0113tas 11. pant\u0101, ieteikumiem.<\/li>\n<\/ul>\n\n<p class=\"wp-block-paragraph\"><strong><em>Citas vesel\u012bguma nor\u0101des, kas nav nor\u0101des par slim\u012bbas riska samazin\u0101\u0161anu un b\u0113rnu att\u012bst\u012bbu un vesel\u012bbu (HCVO 13. pants)<\/em><\/strong><\/p>\n\n<p class=\"wp-block-paragraph\">Pamatojoties uz \u0161iem noteikumiem, Komisija ir izveidojusi Kopienas sarakstu ar vesel\u012bbas nor\u0101d\u0113m, ieskaitot nepiecie\u0161amos nosac\u012bjumus, kas regul\u0113 to izmanto\u0161anu (t\u0101 sauktais 13. panta saraksts). T\u0101d\u0113\u013c dr\u012bkst izmantot min\u0113taj\u0101 sarakst\u0101 nor\u0101d\u012bt\u0101s vesel\u012bbas (citas) nor\u0101des. \u0160eit ir nor\u0101des, kas<\/p>\n\n<ul class=\"wp-block-list\">\n<li>uzturvielas vai citas vielas noz\u012bmi aug\u0161anai, att\u012bst\u012bbai un \u0137erme\u0146a funkcij\u0101m (piem\u0113ram, &#8220;Kalcijs ir svar\u012bgs kauliem&#8221;),<\/li>\n\n\n\n<li>psihisk\u0101s funkcijas vai uzved\u012bbas funkcijas (piem\u0113ram, &#8220;E vitam\u012bns uzlabo koncentr\u0113\u0161an\u0101s sp\u0113jas&#8221;), vai<\/li>\n\n\n\n<li>p\u0101rtikas produkta \u012bpa\u0161\u012bbas, kas padara slaid\u0101ku vai kontrol\u0113 svaru, vai samazina izsalkuma saj\u016btu, vai pastiprina s\u0101ta saj\u016btu, vai samazina ener\u0123ijas uz\u0146em\u0161anu, pat\u0113r\u0113jot p\u0101rtikas produktu (pirms regulas \u0161\u0101d\u0101m tiev\u0113\u0161anas rekl\u0101m\u0101m bija piln\u012bgs aizliegums) (piem\u0113ram: &#8220;satur karnit\u012bnu, kas atbalsta svara samazin\u0101\u0161anas efektu&#8221;). <br\/>Tikai ar Tiesas 2004. gada 15. j\u016blija spriedumu liet\u0101 C-239\/02, Douwe Egberts NV\/Westrom Pharma NV\/FICS-World BVBA, visp\u0101r\u0113js \u0161\u0101das rekl\u0101mas aizliegums tika uzskat\u012bts par Kopienas ties\u012bbu aktiem neatbilsto\u0161u. Attiec\u012bgi \u0161\u0101du nor\u0101\u017eu izmanto\u0161ana ir at\u013cauta, ja pat\u0113r\u0113t\u0101js netiek maldin\u0101ts), <\/li>\n<\/ul>\n\n<p class=\"wp-block-paragraph\">apraksta vai atsaucas uz.<\/p>\n\n<p class=\"wp-block-paragraph\">\u0160\u012bm min\u0113taj\u0101m atsauc\u0113m t\u0101d\u0113\u013c nav nepiecie\u0161ama \u012bpa\u0161a apstiprin\u0101\u0161anas proced\u016bra (skat\u012bt v\u0113l\u0101k), bet t\u0101 viet\u0101 t\u0101m j\u0101atbilst iepriek\u0161 min\u0113taj\u0101m saturiskaj\u0101m pras\u012bb\u0101m, lai t\u0101s tiktu iek\u013cautas t\u0101 sauktaj\u0101 13. panta sarakst\u0101 (<a href=\"https:\/\/eur-lex.europa.eu\/legal-content\/DE\/TXT\/PDF\/?uri=CELEX:02012R0432-20210517&amp;from=EN\">https:\/\/eur-lex.europa.eu\/legal-content\/DE\/TXT\/PDF\/?uri=CELEX:02012R0432-20210517&amp;from=EN<\/a>) (pa\u0161laik p\u0113d\u0113j\u0101 sp\u0113k\u0101 eso\u0161\u0101 versija), k\u0101 ar\u012b j\u0101sniedz zin\u0101tnisks pier\u0101d\u012bjums un j\u0101atbilst pat\u0113r\u0113t\u0101ju izpratnes pras\u012bb\u0101m.<\/p>\n\n<p class=\"wp-block-paragraph\">Tom\u0113r ikviens var piepras\u012bt \u0161\u012b saraksta papildin\u0101jumus, izmantojot vienk\u0101r\u0161otu apstiprin\u0101\u0161anas proced\u016bru (18. pants), ja \u0161\u012bs v\u0113lam\u0101s nor\u0101des ir balst\u012btas uz jauniem zin\u0101tniskiem pier\u0101d\u012bjumiem. Tom\u0113r iz\u0146\u0113mums ir nor\u0101des par b\u0113rnu att\u012bst\u012bbu un vesel\u012bbu, kuras tiek apstiprin\u0101tas saska\u0146\u0101 ar 15., 16., 17. un 19. panta proced\u016bru (individu\u0101la apstiprin\u0101\u0161anas proced\u016bra) (skat\u012bt zem\u0101k). Ar\u012b p\u0113c Komisijas iniciat\u012bvas vai p\u0113c dal\u012bbvalsts piepras\u012bjuma min\u0113to sarakstu var groz\u012bt, \u0146emot v\u0113r\u0101 regulat\u012bvo proced\u016bru saska\u0146\u0101 ar regulas 25. panta 3. punktu. Min\u0113t\u0101 vienk\u0101r\u0161ot\u0101 apstiprin\u0101\u0161anas proced\u016bra (ko var ierosin\u0101t ikviens) sav\u0101 pamatstrukt\u016br\u0101 atbilst stingr\u0101kai individu\u0101lai apstiprin\u0101\u0161anas proced\u016brai (skat\u012bt zem\u0101k par nor\u0101d\u0113m saska\u0146\u0101 ar regulas 14. pantu) saska\u0146\u0101 ar HCVO 15. \u2013 17. pantu. B\u016btisk\u0101k\u0101 at\u0161\u0137ir\u012bba sa\u012bsin\u0101taj\u0101 l\u0113mumu pie\u0146em\u0161anas proced\u016br\u0101 ir t\u0101, ka Komisijai ir ekskluz\u012bvas l\u0113mumu pie\u0146em\u0161anas ties\u012bbas. Kam\u0113r individu\u0101l\u0101s apstiprin\u0101\u0161anas gad\u012bjum\u0101 saska\u0146\u0101 ar 15. un turpm\u0101kajiem pantiem par pieteikumu lemj regulat\u012bvaj\u0101 proced\u016br\u0101 ar kontroli saska\u0146\u0101 ar 2. pantu, \u0161eit Komisija p\u0113c EFSA (Eiropas P\u0101rtikas nekait\u012bguma iest\u0101de) pozit\u012bva atzinuma 2 m\u0113ne\u0161u laik\u0101 pie\u0146em l\u0113mumu viena pati.<\/p>\n\n<p class=\"wp-block-paragraph\"><strong><em>Apgalvojumi par slim\u012bbu riska samazin\u0101\u0161anu un apgalvojumi par b\u0113rnu att\u012bst\u012bbu un vesel\u012bbu (HCVO 14. pants)<\/em><\/strong><\/p>\n\n<p class=\"wp-block-paragraph\">Regula ar\u012b nosaka apstiprin\u0101\u0161anas proced\u016bru vesel\u012bbas apgalvojumiem par slim\u012bbu riska samazin\u0101\u0161anu, k\u0101 ar\u012b apgalvojumiem par b\u0113rnu att\u012bst\u012bbu un vesel\u012bbu.<\/p>\n\n<p class=\"wp-block-paragraph\">Tie ir apgalvojumi, kuros p\u0101rtika tiek reklam\u0113ta k\u0101 t\u0101da, kas vai nu samazina noteiktus slim\u012bbu riskus, vai ar\u012b pozit\u012bvi ietekm\u0113 b\u0113rnu att\u012bst\u012bbu un vesel\u012bbu.<\/p>\n\n<p class=\"wp-block-paragraph\">Piem\u0113rs: &#8220;Regul\u0101ra E vitam\u012bna lieto\u0161ana samazina risku saslimt ar aterosklerozi&#8221;.<\/p>\n\n<p class=\"wp-block-paragraph\">\u0160\u012bm nor\u0101d\u0113m regula paredz individu\u0101las apstiprin\u0101\u0161anas proced\u016bras saska\u0146\u0101 ar regulas 15. un turpm\u0101kajiem pantiem. T\u0101d\u0113\u013c \u0161\u012bs nor\u0101des netiek apstiprin\u0101tas, (autom\u0101tiski) iek\u013caujot Kopienas sarakst\u0101 saska\u0146\u0101 ar 13. panta punktu. 3 regulas, k\u0101 tas ir citu vesel\u012bbas nor\u0101\u017eu gad\u012bjum\u0101. Papildus apstiprin\u0101\u0161anas pras\u012bbai \u0161\u012bm nor\u0101d\u0113m, protams, j\u0101atbilst ar\u012b visp\u0101r\u0113jiem principiem un nosac\u012bjumiem (skat\u012bt iepriek\u0161).<\/p>\n\n<p class=\"wp-block-paragraph\">T\u0101d\u0113\u013c apgalvojumus par slim\u012bbu riska samazin\u0101\u0161anu var izteikt tikai tad, ja to izmanto\u0161anai ir uzs\u0101kta un apstiprin\u0101ta apstiprin\u0101\u0161anas proced\u016bra iek\u013cau\u0161anai sarakst\u0101.<\/p>\n\n<p class=\"wp-block-paragraph\">Papildus 13. panta sarakstam t\u0101d\u0113\u013c ir ar\u012b saraksti par apstiprin\u0101t\u0101m nor\u0101d\u0113m, kas attiecas uz slim\u012bbu riska samazin\u0101\u0161anu. Tie izriet no regul\u0101m Nr. 1226\/2014 un Nr. 1228\/2014. Saite uz regulu 1228\/2014: <a href=\"https:\/\/eur-lex.europa.eu\/legal-content\/DE\/TXT\/PDF\/?uri=CELEX:32014R1228&amp;from=DE\">https:\/\/eur-lex.europa.eu\/legal-content\/DE\/TXT\/PDF\/?uri=CELEX:32014R1228&amp;from=DE<\/a>.<\/p>\n\n<p class=\"wp-block-paragraph\">Saite uz Regulu 1226\/2014: <a href=\"https:\/\/eur-lex.europa.eu\/legal-content\/DE\/TXT\/PDF\/?uri=CELEX:32014R1226&amp;from=DE\">https:\/\/eur-lex.europa.eu\/legal-content\/LV\/TXT\/PDF\/?uri=CELEX:32014R1226&amp;from=LV<\/a> <\/p>\n\n<p class=\"wp-block-paragraph\">Papildus \u0161ai (apstiprin\u0101\u0161anas proced\u016brai) un visp\u0101r\u0113j\u0101m pras\u012bb\u0101m, p\u0101rtikas mar\u0137\u0113jumam vai, ja t\u0101da nav, p\u0101rtikas noform\u0113jumam un rekl\u0101mai j\u0101satur pazi\u0146ojums, ka apgalvojum\u0101 min\u0113t\u0101 slim\u012bba ir atkar\u012bga no vair\u0101kiem faktoriem un ka viena no \u0161iem faktoriem izmai\u0146as var vai nevar rad\u012bt pozit\u012bvu ietekmi. <\/p>\n<a class=\"mr-cta-link mr-cta-button-cal\" href=\"#h2-booking\" title=\"Bezmaksas s\u0101kotn\u0113j\u0101 konsult\u0101cija\"><span class=\"mr-cta-link-normal\">Izv\u0113lieties v\u0113lamo tik\u0161an\u0101s laiku tagad:<\/span><span class=\"mr-cta-link-bold\">Bezmaksas s\u0101kotn\u0113j\u0101 konsult\u0101cija<\/span><\/a>\n\n<h2 class=\"wp-block-heading\" id=\"h-zulassungsverfahren\">Apstiprin\u0101\u0161anas proced\u016bra<\/h2>\n\n<p class=\"wp-block-paragraph\">Individu\u0101l\u0101 apstiprin\u0101\u0161anas proced\u016bra ir sadal\u012bta tr\u012bs posmos:<\/p>\n\n<ul class=\"wp-block-list\">\n<li>pieteikuma iesnieg\u0161ana (15. pants),<\/li>\n\n\n\n<li>EFSA (Eiropas P\u0101rtikas nekait\u012bguma iest\u0101de) pieteikuma priek\u0161meta nov\u0113rt\u0113\u0161ana un atzinums (16. pants) un<\/li>\n\n\n\n<li>Komisijas apgalvojumu apstiprin\u0101\u0161ana komitejas proced\u016bras ietvaros (17. pants).<\/li>\n<\/ul>\n\n<p class=\"wp-block-paragraph\">Pieteikumu individu\u0101lai apstiprin\u0101\u0161anai, pamatojoties uz ES p\u0101rredzam\u012bbas regulu, kop\u0161 2021. gada 29. marta iesniedz tikai elektroniski, izmantojot jauno e-iesnieg\u0161anas platformu (ESFC). Katr\u0101 pieteikuma veidlap\u0101 dr\u012bkst piepras\u012bt tikai vienas vesel\u012bbas nor\u0101des izmanto\u0161anas apstiprin\u0101jumu. Turkl\u0101t ir at\u013cauts att\u0113lot tikai saist\u012bbu starp prec\u012bzi defin\u0113tu ietekmi uz vesel\u012bbu uz vienu reklam\u0113to p\u0101rtikas produktu vai p\u0101rtikas produktu kategoriju vai uzturvielu vai vielu. <\/p>\n\n<p class=\"wp-block-paragraph\">Atsauces uz visp\u0101r\u012bgiem, nespecifiskiem uzturvielas vai p\u0101rtikas produkta ieguvumiem vesel\u012bbai kopum\u0101 vai ar vesel\u012bbu saist\u012btu labsaj\u016btu saska\u0146\u0101 ar 10. panta punktu. 3 HCVO ir at\u013cautas tikai tad, ja t\u0101m ir pievienota \u012bpa\u0161a vesel\u012bbas nor\u0101de, kas iek\u013cauta vien\u0101 no sarakstiem saska\u0146\u0101 ar 13. vai 14. pantu (skat\u012bt iepriek\u0161).<\/p>\n\n<p class=\"wp-block-paragraph\">Ja Komisijas l\u0113mums (t.i., atteikuma gad\u012bjum\u0101 vai nosakot nesam\u0113r\u012bgus nosac\u012bjumus) pieteikuma iesniedz\u0113jam ir ties\u012bbas iesniegt pras\u012bbu par atcel\u0161anu Eiropas Savien\u012bbas Ties\u0101 saska\u0146\u0101 ar LESD 263. pantu (ex-EKL 230. panta 4. punktu). Savien\u012bbas ties\u012bbu aktos noteiktais termi\u0146\u0161 pras\u012bbas iesnieg\u0161anai ir divi m\u0113ne\u0161i, un to var pagarin\u0101t v\u0113l par 10 dien\u0101m saska\u0146\u0101 ar Pirm\u0101s instances tiesas procesu\u0101lo reglamentu.<\/p>\n<a class=\"mr-cta-link mr-cta-button-cal\" href=\"#h2-booking\" title=\"Bezmaksas s\u0101kotn\u0113j\u0101 konsult\u0101cija\"><span class=\"mr-cta-link-normal\">Izv\u0113lieties v\u0113lamo tik\u0161an\u0101s laiku tagad:<\/span><span class=\"mr-cta-link-bold\">Bezmaksas s\u0101kotn\u0113j\u0101 konsult\u0101cija<\/span><\/a>\n\n<h2 class=\"wp-block-heading\" id=\"h-eu-gemeinschaftsregister-art-20-hcvo\">ES Kopienas re\u0123istrs (HCVO 20. pants)<\/h2>\n\n<p class=\"wp-block-paragraph\">Komisija uztur Kopienas re\u0123istru. Tam j\u0101sniedz p\u0101rskats par visiem apstiprin\u0101tajiem un noraid\u012btajiem vesel\u012bbas un uzturv\u0113rt\u012bbas apgalvojumiem. T\u0101d\u0113j\u0101di tas satur inform\u0101ciju par<\/p>\n\n<ul class=\"wp-block-list\">\n<li>apstiprin\u0101tiem uzturv\u0113rt\u012bbas apgalvojumiem,<\/li>\n\n\n\n<li>at\u013cautiem vesel\u012bbas apgalvojumiem saska\u0146\u0101 ar 13. un 14. pantu,<\/li>\n\n\n\n<li>noraid\u012btiem apgalvojumiem,<\/li>\n\n\n\n<li>vesel\u012bguma nor\u0101des ar &#8220;On Hold&#8221; statusu<\/li>\n<\/ul>\n\n<p class=\"wp-block-paragraph\">Saite uz re\u0123istru: <a href=\"https:\/\/ec.europa.eu\/food\/safety\/labelling_nutrition\/claims\/register\/public\/?event=register.home\">https:\/\/ec.europa.eu\/food\/safety\/labelling_nutrition\/claims\/register\/public\/?event=register.home<\/a><\/p>\n\n<h2 class=\"wp-block-heading\" id=\"h-allgemeines-zur-verwendung-formulierung-von-angaben-im-sinne-der-hcvo\">Visp\u0101r\u012bga inform\u0101cija par apgalvojumu izmanto\u0161anu\/formul\u0113\u0161anu HCVO izpratn\u0113<\/h2>\n\n<p class=\"wp-block-paragraph\"><strong>Pirmais solis<\/strong><\/p>\n\n<p class=\"wp-block-paragraph\">Ja tiek pl\u0101nots mar\u0137\u0113t produktu ar uzturv\u0113rt\u012bbas un\/vai vesel\u012bbas nor\u0101di, ieteicams vispirms iepaz\u012bties ar eso\u0161o Kopienas re\u0123istru un sarakstiem. Par at\u013cauto uzturv\u0113rt\u012bbas nor\u0101\u017eu sarakstu skat\u012bt iepriek\u0161 punkt\u0101. 2.2.3.<\/p>\n\n<p class=\"wp-block-paragraph\">Saska\u0146\u0101 ar re\u0123istru apstiprin\u0101tus vesel\u012bbas apgalvojumus var izmantot jebkur\u0101 laik\u0101, \u0146emot v\u0113r\u0101 lieto\u0161anas nosac\u012bjumus vai iesp\u0113jamos ierobe\u017eojumus attiec\u012bgajam produktam. Tom\u0113r vienm\u0113r j\u0101\u0146em v\u0113r\u0101 visp\u0101r\u0113jie principi un nosac\u012bjumi, k\u0101 ar\u012b mar\u0137\u0113\u0161anas pien\u0101kums.<\/p>\n\n<p class=\"wp-block-paragraph\">J\u0101\u0146em v\u0113r\u0101 ar\u012b tas, ka neat\u013cautu nor\u0101\u017eu izmanto\u0161ana parasti ir aizliegta. Turkl\u0101t visus (apstiprin\u0101tos) vesel\u012bbas apgalvojumus dr\u012bkst sniegt tikai par tiem p\u0101rtikas produktiem, p\u0101rtikas produktu kategorij\u0101m vai uzturviel\u0101m, kuriem tie s\u0101kotn\u0113ji tika apstiprin\u0101ti, un nek\u0101d\u0101 gad\u012bjum\u0101 par produktiem, kas tos satur.<\/p>\n\n<p class=\"wp-block-paragraph\"><strong>Piem\u0113rs:<\/strong><\/p>\n\n<p class=\"wp-block-paragraph\">T\u0101d\u0113j\u0101di nepie\u013caujama b\u016btu \u0161\u0101da vesel\u012bbas nor\u0101de: &#8220;Produkts X pal\u012bdz uztur\u0113t zobu vesel\u012bbu&#8221;. \u0160aj\u0101 zi\u0146\u0101 pie\u013caujama b\u016btu: &#8220;Produkts X satur D vitam\u012bnu un kalciju, kas pal\u012bdz uztur\u0113t norm\u0101lu zobu vesel\u012bbu.&#8221;<\/p>\n\n<p class=\"wp-block-paragraph\">Nepie\u013caujami: &#8220;Gl\u0101ze apels\u012bnu sulas pal\u012bdz mazin\u0101t nogurumu un nesp\u0113ku&#8221;. Pie\u013caujami: &#8220;C vitam\u012bns gl\u0101z\u0113 apels\u012bnu sulas pal\u012bdz mazin\u0101t nogurumu un nesp\u0113ku.&#8221; (Teufer, GRUR-Prax 2012, 476\/477 p\u0113c OLG Bamberg).<\/p>\n\n<p class=\"wp-block-paragraph\">Ja mekl\u0113tais apgalvojums nav ne apstiprin\u0101ts, ne noraid\u012bts vai nav atrodams visp\u0101r\u0113j\u0101 datub\u0101z\u0113, tad \u0161o apgalvojumu ac\u012bmredzot v\u0113l neviens nav iesniedzis apstiprin\u0101\u0161anai. \u0160\u0101dus apgalvojumus nedr\u012bkst izmantot. Tom\u0113r, ja ir pieejami visaptvero\u0161i zin\u0101tniski p\u0113t\u012bjumi, kas pier\u0101da ietekmi, tad \u0161\u012bs nor\u0101des var iesniegt apstiprin\u0101\u0161anas proced\u016br\u0101.<\/p>\n\n<p class=\"wp-block-paragraph\"><strong>Formul\u0113jums<\/strong><\/p>\n\n<p class=\"wp-block-paragraph\">Ja apgalvojumi jau ir apstiprin\u0101ti, to formul\u0113jums ir atrodams Kopienas saraksta otraj\u0101 tabulas ail\u0113.<\/p>\n\n<p class=\"wp-block-paragraph\">\u0160im formul\u0113jumam j\u0101atspogu\u013co zin\u0101tniski pamatota p\u0101rtikas produkta vai konkr\u0113tas uzturvielas ietekme uz cilv\u0113ka vesel\u012bbu.<\/p>\n\n<p class=\"wp-block-paragraph\">Rodas jaut\u0101jums, vai ir pie\u013caujama atk\u0101pe no \u0161\u012b skaidr\u0101 formul\u0113juma. Regulas 432\/2012 (par 13. panta sarakstu) 9. apsv\u0113rum\u0101 likumdev\u0113js nor\u0101da, ka ar regulu ir j\u0101nodro\u0161ina, ka vesel\u012bbas nor\u0101des ir patiesas, skaidras, uzticamas un noder\u012bgas pat\u0113r\u0113t\u0101jam. \u0160aj\u0101 kontekst\u0101 ir j\u0101v\u0113rt\u0113 nor\u0101\u017eu formul\u0113jums un noform\u0113jums. Ties\u012bbu eksperti no \u0161\u012bs rindkopas secina, ka zin\u0101ma atsevi\u0161\u0137u nor\u0101\u017eu elast\u012bba, iesp\u0113jams, ir pie\u013caujama. Tas ir tik ilgi, kam\u0113r t\u0101d\u0113j\u0101di tiek pan\u0101kts, ka vidusm\u0113ra pat\u0113r\u0113t\u0101js lab\u0101k saprot. Tom\u0113r jebkur\u0101 gad\u012bjum\u0101 j\u0101\u0146em v\u0113r\u0101 da\u017e\u0101das pat\u0113r\u0113t\u0101ju m\u0113r\u0137grupas, k\u0101 ar\u012b valodu un kult\u016bras at\u0161\u0137ir\u012bbas. Galu gal\u0101 iz\u0161\u0137iro\u0161ais ir tas, ka formul\u0113jums p\u0113c b\u016bt\u012bbas ir l\u012bdzv\u0113rt\u012bgs Kopienas re\u0123istr\u0101 iek\u013cautajam.<\/p>\n<a class=\"mr-cta-link mr-cta-button-cal\" href=\"#h2-booking\" title=\"Bezmaksas s\u0101kotn\u0113j\u0101 konsult\u0101cija\"><span class=\"mr-cta-link-normal\">Izv\u0113lieties v\u0113lamo tik\u0161an\u0101s laiku tagad:<\/span><span class=\"mr-cta-link-bold\">Bezmaksas s\u0101kotn\u0113j\u0101 konsult\u0101cija<\/span><\/a>\n\n<h2 class=\"wp-block-heading\" id=\"h-rechtsberatung-rechtsvertretung\">Juridisk\u0101s konsult\u0101cijas \/ Juridisk\u0101 p\u0101rst\u0101v\u012bba<\/h2>\n\n<p class=\"wp-block-paragraph\">M\u0113s ar prieku atbalst\u012bsim J\u016bs visos juridiskajos jaut\u0101jumos saist\u012bb\u0101 ar Vesel\u012bbas nor\u0101\u017eu regulu. Bezmaksas s\u0101kotn\u0113j\u0101s konsult\u0101cijas laik\u0101 m\u0113s ar prieku apspried\u012bsim ar Jums ide\u0101lo pieeju J\u016bsu juridiskajiem jaut\u0101jumiem. <\/p>\n<a class=\"mr-cta-link mr-cta-button-cal\" href=\"#h2-booking\" title=\"Bezmaksas s\u0101kotn\u0113j\u0101 konsult\u0101cija\"><span class=\"mr-cta-link-normal\">Izv\u0113lieties v\u0113lamo tik\u0161an\u0101s laiku tagad:<\/span><span class=\"mr-cta-link-bold\">Bezmaksas s\u0101kotn\u0113j\u0101 konsult\u0101cija<\/span><\/a>\n","protected":false},"excerpt":{"rendered":"Vesel\u012bbas apgalvojumi Visp\u0101r\u012bgi run\u0101jot, ar vesel\u012bbas nor\u0101d\u0113m saprot vesel\u012bbu saist\u012btus apgalvojumus vai att\u0113lojumus par p\u0101rtikas produktiem, kas apraksta saist\u012bbu starp p\u0101rtikas produktu vai k\u0101du no t\u0101 sast\u0101vda\u013c\u0101m un vesel\u012bbu. Realit\u0101t\u0113 &#8230;","protected":false},"author":1,"featured_media":0,"parent":57910,"menu_order":0,"comment_status":"closed","ping_status":"open","template":"","meta":{"_acf_changed":false,"_uag_custom_page_level_css":"","footnotes":""},"categories":[1283],"tags":[],"class_list":["post-65659","page","type-page","status-publish","hentry","category-konkurences-tiesibas"],"acf":[],"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"336x":false,"352x":false,"woocommerce_thumbnail":false,"woocommerce_single":false,"woocommerce_gallery_thumbnail":false,"yarpp-thumbnail":false},"uagb_author_info":{"display_name":"Peter Harlander","author_link":"https:\/\/harlander-partner.eu\/lv\/author\/secondpromotion\/"},"uagb_comment_info":0,"uagb_excerpt":"Vesel\u012bbas apgalvojumi Visp\u0101r\u012bgi run\u0101jot, ar vesel\u012bbas nor\u0101d\u0113m saprot vesel\u012bbu saist\u012btus apgalvojumus vai att\u0113lojumus par p\u0101rtikas produktiem, kas apraksta saist\u012bbu starp p\u0101rtikas produktu vai k\u0101du no t\u0101 sast\u0101vda\u013c\u0101m un vesel\u012bbu. Realit\u0101t\u0113 ...","_links":{"self":[{"href":"https:\/\/harlander-partner.eu\/lv\/wp-json\/wp\/v2\/pages\/65659","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/harlander-partner.eu\/lv\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/harlander-partner.eu\/lv\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/harlander-partner.eu\/lv\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/harlander-partner.eu\/lv\/wp-json\/wp\/v2\/comments?post=65659"}],"version-history":[{"count":1,"href":"https:\/\/harlander-partner.eu\/lv\/wp-json\/wp\/v2\/pages\/65659\/revisions"}],"predecessor-version":[{"id":162169,"href":"https:\/\/harlander-partner.eu\/lv\/wp-json\/wp\/v2\/pages\/65659\/revisions\/162169"}],"up":[{"embeddable":true,"href":"https:\/\/harlander-partner.eu\/lv\/wp-json\/wp\/v2\/pages\/57910"}],"wp:attachment":[{"href":"https:\/\/harlander-partner.eu\/lv\/wp-json\/wp\/v2\/media?parent=65659"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/harlander-partner.eu\/lv\/wp-json\/wp\/v2\/categories?post=65659"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/harlander-partner.eu\/lv\/wp-json\/wp\/v2\/tags?post=65659"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}